Equipalazone^®

Equipalazone^® 1 g Oral Powder is indicated in the treatment of musculoskeletal disorders in horses and ponies where the anti-inflammatory and analgesic properties of phenylbutazone can offer relief, for example, in lameness associated with osteoarthritic conditions, acute and chronic laminitis, bursitis and carpitis, and in the reduction of post-surgical soft tissue reaction.

Active Ingredient:

Phenylbutazone in 1g sachets of oral powder. Micro-encapsulated with apple flavouring.

Actions:

Phenylbutazone is a non-steroidal anti-inflammatory medication. NSAIDs work primarily by inhibiting cyclo-oxygenase (COX) enzymes within the inflammatory pathway, reducing synthesis of prostaglandins and related inflammatory mediators.

Indications:

For the treatment of inflammation and pain associated with musculoskeletal disorders including lameness associated with osteoarthritic conditions, laminitis, bursitis, carpitis and in the reduction of post surgical soft tissue reaction.

Dosage and Administration:

For oral only administration with a small quantity of feed.
Horses 450 kg body weight: Two sachets to be administered twice on day one (equivalent to 8.8 mg/kg/day) followed by one sachet twice daily for four days (4.4 mg/kg/day), then one sachet daily or on alternate days sufficient to keep the horse comfortable (2.2 mg/kg/day).
Ponies 225 kg body weight: One sachet (4.4 mg/kg/day) on alternate days. Adjust dose according to body weight. Discontinue treatment if no response is evident after four to five days treatment.